dCBP-1 is a potent and selective heterobifunctional degrader of p300/CBP by hijacking the E3 ubiquitin ligase CRBN, also is exceptionally potent at killing multiple myeloma cells and can abolish the enhancer that drives MYC oncogene expression.
[1] Vannam R, et al. Cell Chem Biol. 2021 Apr 15;28(4):503-514.e12.
















